OPKO Health Inc. (NASDAQ:OPK) went up by 7.58% from its latest closing price compared to the recent 1-year high of $6.47. The company’s stock price has collected 20.98% of gains in the last five trading sessions. Press Release reported on 09/15/20 that OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
Is It Worth Investing in OPKO Health Inc. (NASDAQ :OPK) Right Now?
Plus, the 36-month beta value for OPK is at 1.93. Opinions of the stock are interesting as 4 analysts out of 5 who provided ratings for OPKO Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $8.00. OPK currently public float of 403.11M and currently shorts hold a 32.66% ratio of that float. Today, the average trading volume of OPK was 17.56M shares.
OPK’s Market Performance
OPK stocks went up by 20.98% for the week, with a monthly jump of 13.89% and a quarterly performance of 7.58%, while its annual performance rate touched 84.50%. The volatility ratio for the week stands at 6.00% while the volatility levels for the past 30 days are set at 7.00% for OPKO Health Inc.. The simple moving average for the period of the last 20 days is 16.92% for OPK stocks with a simple moving average of 41.11% for the last 200 days.
Analysts’ Opinion of OPK
Many brokerage firms have already submitted their reports for OPK stocks, with Piper Jaffray repeating the rating for OPK by listing it as a “Overweight.” The predicted price for OPK in the upcoming period, according to Piper Jaffray is $2.50 based on the research report published on November 25th of the previous year 2019.
OPK Trading at -13.87% from the 50-Day Moving Average
After a stumble in the market that brought OPK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.97% of loss for the given period.
Volatility was left at 7.00%, however, over the last 30 days, the volatility rate increased by 6.00%, as shares surge +17.52% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -38.04% lower at present.
During the last 5 trading sessions, OPK rose by +20.98%, which changed the moving average for the period of 200-days by +136.54% in comparison to the 20-day moving average, which settled at $3.18. In addition, OPKO Health Inc. saw 151.02% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at OPK starting from Rubin Steven D, who purchase 10,000 shares at the price of $3.99 back on Aug 26. After this action, Rubin Steven D now owns 6,167,732 shares of OPKO Health Inc., valued at $39,943 using the latest closing price.
FROST PHILLIP MD ET AL, the CEO & Chairman of OPKO Health Inc., purchase 100,000 shares at $2.27 during a trade that took place back on Jun 03, which means that FROST PHILLIP MD ET AL is holding 190,221,694 shares at $227,000 based on the most recent closing price.
Stock Fundamentals for OPK
Current profitability levels for the company are sitting at:
- -21.79 for the present operating margin
- +29.34 for the gross margin
The net margin for OPKO Health Inc. stands at -34.92. The total capital return value is set at -9.99, while invested capital returns managed to touch -16.27. Equity return is now at value -12.50, with -8.70 for asset returns.
Based on OPKO Health Inc. (OPK), the company’s capital structure generated 19.57 points at debt to equity in total, while total debt to capital is 16.37. Total debt to assets is 13.68, with long-term debt to equity ratio resting at 18.06. Finally, the long-term debt to capital ratio is 15.10.
When we switch over and look at the enterrpise to sales, we see a ratio of 1.23, with the company’s debt to enterprise value settled at 0.29. The receivables turnover for the company is 5.64 and the total asset turnover is 0.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.30.